Inicio>>Signaling Pathways>> Proteases>> Aldehyde Dehydrogenase (ALDH)>>ALDH1A1-IN-2

ALDH1A1-IN-2

Catalog No.GC64063

ALDH1A1-IN-2 es un potente inhibidor de la aldehÍdo deshidrogenasa 1a1 (aldh1a1). Las aldehÍdos deshidrogenasas (ALDH) constituyen una familia de enzimas que juegan un papel crÍtico en la oxidaciÓn de varios aldehÍdos citotÓxicos xenogénicos y biogénicos. ALDH1A1-IN-2 tiene el potencial para la investigaciÓn del cÁncer, la inflamaciÓn o la obesidad (extraÍdo de la patente WO2019089626A1, compuesto 295).

Products are for research use only. Not for human use. We do not sell to patients.

ALDH1A1-IN-2 Chemical Structure

Cas No.: 2231081-18-6

Tamaño Precio Disponibilidad Cantidad
5 mg
315,00 $
Disponible
10 mg
504,00 $
Disponible
25 mg
1.008,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

ALDH1A1-IN-2 is a potent inhibitor of aldehyde dehydrogenase 1a1 (aldh1a1). Aldehyde dehydrogenases (ALDH) constitute a family of enzymes that play a critical role in oxidizing various cytotoxic xenogenic and biogenic aldehydes. ALDH1A1-IN-2 has the potential for the research of cancer, inflammation, or obesity (extracted from patent WO2019089626A1, compound 295)[1].

[1]. Shyh Ming YANG, et al. Substituted quinoline analogs as aldehyde dehydrogenase 1a1 (aldh1a1) inhibitors. Patent WO2019089626A1.

Reseñas

Review for ALDH1A1-IN-2

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ALDH1A1-IN-2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.